The synbiotics by Probi and Clasado combine the most researched probiotic strains with the most comprehensively studied galactooligosaccharide (GOS) prebiotic available on the market. These synbiotic concepts represent truly scientifically backed combinations, offering either a unique and novel gut health position or an overall gut-immune concept.
Hear from our panel of experts who will be discussing a range of topics, from the latest synbiotic trends, insights from the recent synbiotic research demonstrating a synergistic relationship, and then wrapping up with how synbiotics can add scientific value to meet not just today, but tomorrow’s consumer needs.
Caroline Montelius, PhD – Department Manager Scientific Affairs, (Probi)
Christina Vegge, PhD – Senior R&D Director (Probi)
Dr Lucien Harthoorn – R&D Director (Clasado)
Dr Frederic Narbel – VP of B2B Sales (Clasado)
Because local laws and regulations related to the distribution, marketing and sale of ingredients and finished products vary, Probi disclaims any regulatory compliance, warranties, product guidance or instruction of any kind. This brochure is provided for business-to-business communication and educational purposes only without warranties of any kind. Users should seek legal and/or regulatory advice prior to the market introduction of any Probi strain and before use of any claims to ensure compliance and thereafter on an ongoing basis when required.
just a testing value, ignore this string please
Related Information
The probiotic and prebiotic components can interact in one of two ways. With a synergistic synbiotic, the prebiotic substrate...
Related information
Probi® has spent more than thirty years investigating the safety and efficacy of our probiotic strains. We conduct...
Related information
Probi is an innovative, experienced provider of clinically proven probiotic strains and solutions. We use our state-of-the-art...
